Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development

Glycobiology

Volumn 16, Issue 6, 2006, Pages 551-563

  Whisenhunt, Thomas R ^a,b   Yang, Xiaoyong ^e   Bowe, Damon B ^c   Paterson, Andrew J ^d   Van Tine, Brian A ^b   Kudlow, Jeffrey E ^a,c,d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

^e SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Corepressor; Estrogen; HAT; O GlcNAcase; OGT

Indexed keywords

CYTOPLASM PROTEIN; ESTRADIOL; GREEN FLUORESCENT PROTEIN; HISTONE DEACETYLASE; N ACETYLGLUCOSAMINYLACETYLTRANSFERASE; N ACETYLGLUCOSAMINYLTRANSFERASE; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SUBSTRATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ACETYLGLUCOSAMINE; ACETYLGLUCOSAMINIDASE; ANIMALS; BETA-N-ACETYLHEXOSAMINIDASE; CELL LINE; ESTROGENS; FEMALE; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; MULTIENZYME COMPLEXES; N-ACETYLGLUCOSAMINYLTRANSFERASES; SIGNAL TRANSDUCTION;

ANIMALIA; MUS MUSCULUS;

EID: 33646890020     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwj096     Document Type: Article

References (48)

1. Bjorklund, S., Almouzni, G., Davidson, I., Nightingale, K.P., and Weiss, K. (1999) Global transcription regulators of eukaryotes. Cell, 96, 759-767.
2. Bowe, D.B., Kenney, N.J., Adereth, Y., and Maroulakou, I.G. (2002) Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E. Oncogene, 21, 291-298.
3. Comer, F.I. and Hart, G.W. (2001) Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry, 40, 7845-7852.
4. Comtesse, N., Maldener, E., and Meese, E. (2001) Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a beta-N-acetylglucosaminidase. Biochem. Biophys. Res. Commun., 283, 634-640.
5. Gao, Y., Wells, L., Comer, F.I., Parker, G.J., and Hart, G.W. (2001) Dynamic O-glycosylation of nuclear and cytosolic proteins: Cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J. Biol. Chem., 276, 9838-9845.
6. Glass, C.K. and Rosenfeld, M.G. (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev., 14, 121-141.
7. Goldberg, H.J., Whiteside, C.I., Hart, G.W., and Fantus, I.G. (2006) Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 (PAI-1) gene expression and Sp1 transcriptional activity in glomerular mesangial cells. Endocrinology, 147, 222-231.
8. Hahn, S. (1998) The role of TAFs in RNA polymerase II transcription. Cell, 95, 579-582.
9. Hartweck, L.M., Scott, C.L., and Olszewski, N.E. (2002) Two O-linked N-acetylglucosamine transferase genes of Arabidopsis thaliana L. Heynh. have overlapping functions necessary for gamete and seed development. Genetics, 161, 1279-1291.
10. Heinzel, T., Lavinsky, R.M., Mullen, T.M., Soderstrom, M., Laherty, C.D., Torchia, J., Yang, W.M., Brard, G., Ngo, S.D., Davie, J.R., and others. (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression [see comments]. Nature, 387, 43-48.
11. Ishizuka, T. and Lazar, M.A. (2003) The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor. Mol. Cell Biol., 23, 5122-5131.
12. Jackson, S.P. and Tjian, R. (1988) O-glycosylation of eukaryotic transcription factors: Implications for mechanisms of transcriptional regulation. Cell, 55, 125-133.
13. Jiang, M.S. and Hart, G.W. (1997) A subpopulation of estrogen receptors are modified by O-linked N-acetylglucosamine. J. Biol. Chem., 272, 2421-2428.
14. Khan, S., Abdelrahim, M., Samudio, I., and Safe, S. (2003) Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells. Endocrinology, 144, 2325-2335.
15. Konrad, R.J., Zhang, F., Hale, J.E., Knierman, M.D., Becker, G.W., and Kudlow, J.E. (2002) Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem. Biophys. Res. Commun., 293, 207-212.
16. Kreppel, L.K., Blomberg, M.A., and Hart, G.W. (1997) Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J. Biol. Chem., 272, 9308-9315.
17. Lazarus, B.D., Love, D.C., and Hanover, J.A. (2006) Recombinant O-GlcNAc transferase isoforms: Identification of O-GlcNAcase, YES tyrosine kinase and Tau as isoform-specific substrates. Glycobiology [Epub ahead of print].
18. Li, X., Oghi, K.A., Zhang, J., Krones, A., Bush, K.T., Glass, C.K., Nigam, S.K., Aggarwal, A.K., Maas, R., Rose, D.W., and Rosenfeld, M.G. (2003) Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature, 426, 247-254.
19. Liu, K., Paterson, A.J., Chin, E., and Kudlow, J.E. (2000) Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: Linkage of O-linked GlcNAc to beta cell death. Proc. Natl. Acad. Sci. U. S. A., 97, 2820-2825.
20. Liu, K., Paterson, A.J., Zhang, F., McAndrew, J., Fukuchi, K., Wyss, J.M., Peng, L., Hu, Y., and Kudlow, J.E. (2004) Accumulation of protein O-GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O-GlcNAc metabolism. J. Neurochem., 89, 1044-1055.
21. Love, D.C., Kochran, J., Cathey, R.L., Shin, S.H., and Hanover, J.A. (2003) Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase. J. Cell Sci., 116, 647-654.
22. McAndrew, J., Paterson, A.J., Asa, S.L., McCarthy, K.J., and Kudlow, J.E. (1995) Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology, 136, 4479-4488.
23. Moss, B., Elroy-Stein, O., Mizukami, T., Alexander, W.A., and Fuerst, T.R. (1990) Product review. New mammalian expression vectors. Nature, 348, 91-92.
24. Nadal, A., Diaz, M., and Valverde, M.A. (2001) The estrogen trinity: membrane, cytosolic, and nuclear effects. News Physiol. Sci., 16, 251-255.
25. Nagy, L., Kao, H.Y., Chakravarti, D., Lin, R.J., Hassig, C.A., Ayer, D.E., Schreiber, S.L., and Evans, R.M. (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell, 89, 373-380.
26. O'Donnell, N. (2002) Intracellular glycosylation and development. Biochim. Biophys. Acta, 1573, 336-345.
27. O'Donnell, N., Zachara, N.E., Hart, G.W., and Marth, J.D. (2004) Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol. Cell Biol., 24, 1680-1690.
28. Perissi, V., Aggarwal, A.K., Glass, C.K., Rose, D.W., and Rosenfeld, M.G. (2004) A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell, 116, 511-526.
29. Perissi, V. and Rosenfeld, M.G. (2005) Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell Biol., 6, 542-554.
30. Pierce, D.F. Jr., Johnson, M.D., Matsui, Y., Robinson, S.D., Gold, L.I., Purchio, A.F., Daniel, C.W., Hogan, B.L., and Moses, H.L. (1993) Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. Genes Dev., 7, 2308-2317.
31. Roh, M., Paterson, A.J., Asa, S.L., Chin, E., and Kudlow, J.E. (2001) Stage-sensitive blockade of pituitary somatomammotrope development by targeted expression of a dominant negative epidermal growth factor receptor in transgenic mice. Mol. Endocrinol., 15, 600-613.
32. Roh, M., Paterson, A.J., Liu, K., McAndrew, J., Chin, E., and Kudlow, J.E. (2005) Proteolytic processing of TGFalpha redirects its mitogenic activity: The membrane-anchored form is autocrine, the secreted form is paracrine. Biochem. Biophys. Acta, 1743, 231-242.
33. Roos, M.D. and Hanover, J.A. (2000) Structure of O-linked GlcNAc transferase: Mediator of glycan-dependent signaling. Biochem. Biophys. Res. Commun., 271, 275-280.
34. Roos, M.D., Su, K., Baker, J.R., and Kudlow, J.E. (1997) O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol. Cell Biol., 17, 6472-6480.
35. Sekinger, E.A. and Gross, D.S. (2001) Silenced chromatin is permissive to activator binding and PIC recruitment. Cell, 105, 403-414.
36. Shang, Y., Hu, X., DiRenzo, J., Lazar, M.A., and Brown, M. (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell, 103, 843-852.
37. Shaw, P., Freeman, J., Bovey, R., and Iggo, R. (1996) Regulation of specific DNA binding by p53: Evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene, 12, 921-930.
38. Shin, T.H., Paterson, A.J., Grant, J.H. III, Meluch, A.A., and Kudlow, J.E. (1992) 5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression. Mol. Cell Biol., 12, 3998-4006.
39. Struhl, K. (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev., 12, 599-606.
40. Toleman, C., Paterson, A.J., Whisenhunt, T.R., and Kudlow, J.E. (2004) Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities. J. Biol. Chem., 279, 53665-53673.
41. Van Tine, B.A., Dao, L.D., Wu, S.Y., Sonbuchner, T.M., Lin, B.Y., Zou, N., Chiang, C.M., Broker, T.R., and Chow, L.T. (2004) Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc. Natl. Acad. Sci. U. S. A., 101, 4030-4035.
42. Wells, L., Vosseller, K., and Hart G.W. (2001) Glycosylation of nucleocytoplasmic proteins: Signal transduction and O-GlcNAc. Science, 291, 2376-2378.
43. Wong, C.W. and Privalsky, M.L. (1998) Transcriptional silencing is defined by isoform- and heterodimer-specific interactions between nuclear hormone receptors and corepressors. Mol. Cell Biol., 18, 5724-5733.
44. Xie, W., Chow, L.T., Paterson, A.J., Chin, E., and Kudlow, J.E. (1999) Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFalpha expression in transgenic mice. Oncogene, 18, 3593-3607.
45. Xie, W., Paterson, A.J., Chin, E., Nabell, L.M., and Kudlow, J.E. (1997) Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol. Endocrinol., 11, 1766-1781.
46. Yang, X., Su, K., Roos, M.D., Chang, Q., Paterson, A.J., and Kudlow, J.E. (2001) O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc. Natl. Acad. Sci. U. S. A., 98, 6611-6616.
47. Yang, X., Zhang, F., and Kudlow, J.E. (2002) Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: Coupling protein O-GlcNAcylation to transcriptional repression. Cell, 110, 69-80.
48. Zhang, F., Su, K., Yang, X., Bowe, D.B., Paterson, A.J., and Kudlow, J.E. (2003) O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell, 115, 715-725.